Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company located in Cambridge, Massachusetts, dedicated to developing innovative therapies for significant unmet medical needs. The company focuses on conditions such as post-bariatric hypoglycemia, Wolfram syndrome, progressive supranuclear palsy, and amyotrophic lateral sclerosis. With a mission driven by urgency and rigorous scientific inquiry, Amylyx fosters a culture of caring through its core values of audacity, curiosity, authenticity, engagement, and accountability. The company is committed to making a meaningful impact on the communities it serves and is powered by a team of experienced professionals ready to tackle challenges in the healthcare landscape.